Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2025-10-21

EMA Authorised: Voriconazole Accord (voriconazole) — Accord Healthcare S.L.U.

View source ↗

Summary

The European Medicines Agency authorised Voriconazole Accord (voriconazole) for treating aspergillosis, candidiasis and other mycoses; the marketing authorisati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Voriconazole Accord (voriconazole)

Snippet

Status: Authorised. Therapeutic area: Aspergillosis;Candidiasis;Mycoses. MAH: Accord Healthcare S.L.U.. Decision date: 17/10/2025